Anthropic的生物学 claims 遭遇速度限制
anthropic 在 ipo 文件中降低生物学 claims，引用缺乏物理实验经验。这影响生物技术投资者和人工智能爱好者。
anthropic, a prominent ai company, has tempered its claims about revolutionizing biology and drug discovery in its recent ipo filing. despite previous statements from ceo dario amodei predicting ai could produce a thousand years of progress in biology in just five to 10 years, the filing acknowledges the company's lack of experience in physical experimentation and the lengthy, costly process of drug development. anthropic now recognizes that its ai-assisted discoveries will face significant regulatory and testing hurdles, potentially taking years to prove their safety and efficacy. this development affects biotech investors, ai enthusiasts, and the broader biotech industry.